BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 6815609)

  • 21. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-E as a cause of hemolytic disease of the newborn.
    Cheepsattayakorn R; Fongsatitkul L; Chotinaruemol S; Mahawongtong M
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S1-4. PubMed ID: 9347637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of hemolytic disease of the newborn caused by materno-fetal isoimmunization against factor c(hr') (preliminary note)].
    De Luca P
    Arch Ostet Ginecol; 1980; 85(3):175-7. PubMed ID: 6802114
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
    Avdeeva RA; Kopp VD; Vasil'eva AF
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
    [No Abstract]   [Full Text] [Related]  

  • 27. [Simultaneous hemolytic diseases in mother and child resulting from a rare form of isoimmunization].
    Joó-Szabados T; Kun E; Hervei S
    Orv Hetil; 1977 Mar; 118(13):757-9. PubMed ID: 403497
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):219-29. PubMed ID: 5004392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Our experience in the field of the ABO hemolytic disease of the newborn].
    Gavinelli R
    Pathologica; 1972; 64(935):329-30. PubMed ID: 4677647
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rh factor: anti-D isoimmunization and its therapeutic possibilities].
    Tucci G; Teofili MT
    Clin Ter; 1967 Dec; 43(6):567-89. PubMed ID: 4979582
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complications and mortality of exchange transfusion in the newborn. (Considerations on 777 interventions)].
    Mencarini L; Ottaviano S; Marzetti G; Ermini M
    Riv Clin Pediatr; 1967; 80(4):70-80. PubMed ID: 4974289
    [No Abstract]   [Full Text] [Related]  

  • 34. [Late mortality after exchange transfusion at birth].
    Baratono S; Grazia G
    Minerva Pediatr; 1972 Apr; 24(14):583-5. PubMed ID: 4623354
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
    Cwik J
    Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 38. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(4):322-8. PubMed ID: 6774626
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mortality of newborn infants with hemolytic disease treated by exchange transfusion. Analysis of 524 cases].
    Polácek K
    Cesk Pediatr; 1967 Dec; 22(12):1059-66. PubMed ID: 4965949
    [No Abstract]   [Full Text] [Related]  

  • 40. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
    Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.